We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 41-60 of 10,000 results
  1. Changes in wider field swept-source OCT angiography vascular metrics with anti-vascular endothelial growth factor therapy in central retinal vein occlusion

    Purpose

    To investigate the impact of anti-VEGF therapy on vascular metrics in eyes with macular edema secondary to central retinal vein occlusion...

    Peyman Razavi, Grace Baldwin, ... John B. Miller in Graefe's Archive for Clinical and Experimental Ophthalmology
    Article 20 February 2024
  2. Vascular endothelial growth factor and the risk of venous thromboembolism: a genetic correlation and two-sample Mendelian randomization study

    Background

    The relationship between vascular endothelial growth factor (VEGF) and the risk of venous thromboembolism (VTE) has always been one of the...

    Qiaoyun Zhang, **aoyu Zhang, ... Youxin Wang in Thrombosis Journal
    Article Open access 08 November 2022
  3. Long-term outcomes of anti-vascular endothelial growth factor therapy with and without posterior scleral reinforcement on myopic maculopathy in myopic choroidal neovascularization eyes

    Background

    Anti-vascular endothelial growth factor (anti-VEGF) therapy is used for myopic choroidal neovascularization (mCNV). Patchy chorioretinal...

    Meng-Tian Kang, Ningli Wang, ... Yue Qi in BMC Ophthalmology
    Article Open access 13 March 2024
  4. Seven-year outcomes following intensive anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration

    Background

    Anti-vascular endothelial growth factor (VEGF) therapy is currently the most effective therapy of exudative age-related macular...

    Regina Lukacs, Miklos Schneider, ... Andras Papp in BMC Ophthalmology
    Article Open access 17 March 2023
  5. Serum vascular endothelial growth factor, insulin-like growth factor-1 and aflibercept levels in retinopathy of prematurity

    Purpose

    To evaluate the serum levels of vascular endothelial growth factor (VEGF) and insulin-like growth factor-1 (IGF-1) after intravitreal...

    Utku Furuncuoglu, Aslı Vural, ... Fadime Ulviye Yigit in Japanese Journal of Ophthalmology
    Article 29 January 2022
  6. Efficacy comparison of anti-vascular endothelial growth factor drugs for the treatment of type 1 retinopathy of prematurity: A network meta-analysis of randomised controlled trials

    Purpose

    To compare the efficacy of different anti-vascular endothelial growth factor (VEGF) agents for the treatment of retinopathy of prematurity...

    Miao Zhou, Kinji Hashimoto, ... Mingwei Zhao in Graefe's Archive for Clinical and Experimental Ophthalmology
    Article 10 October 2023
  7. Cytokine- and Vascular Endothelial Growth Factor-Related Gene-Based Genome-Wide Association Study of Low-Dose Ketamine Infusion in Patients with Treatment-Resistant Depression

    Background and Objective

    Ketamine may work as an anti-inflammatory agent, and it increases the levels of vascular endothelial growth factor (VEGF) in...

    Shih-Jen Tsai, Chung-Feng Kao, ... Mu-Hong Chen in CNS Drugs
    Article 10 February 2023
  8. Cabozantinib and Axitinib After Vascular Endothelial Growth Factor Therapy in Patients with Advanced Renal Cell Carcinoma: A Retrospective Cohort Study from England

    Background and Objective

    The tyrosine kinase inhibitors cabozantinib and axitinib have been widely used in England to treat advanced renal cell...

    Janet Brown, Brooke Harrow, ... Andrew Protheroe in Drugs - Real World Outcomes
    Article Open access 24 January 2024
  9. Recent trends in anti-vascular endothelial growth factor intravitreal injections: a large claims database study in Japan

    Purpose

    To clarify recent trends in the use of intravitreal injections of anti-vascular endothelial growth factor (VEGF) in Japan.

    Study design ...
    Yohei Hashimoto, Akira Okada, ... Ryo Obata in Japanese Journal of Ophthalmology
    Article 12 December 2022
  10. Vascular endothelial growth factor A with two genetic variants for prediction of mixed microvascular diabetic complications

    Background

    Vascular endothelial growth factor (VEGF) is a signal protein, induces cell proliferation, and enhances the permeability of the endothelial...

    Thoria Ahmed Omar, Gehan Kamal El-Saeed, ... Belal Abdelmohsen Montaser in Egyptian Journal of Medical Human Genetics
    Article Open access 16 May 2022
  11. Factors affecting prognosis and need for anti-vascular endothelial growth factor injections in wet age-related macular degeneration

    Purpose

    To understand factors affecting visual prognosis and the number of intravitreal antivascular endothelial growth factor (anti-VEGF) injections...

    Muhammet Emin Kızılay, Gözde Derin Şengün, ... Veysel Aykut in International Ophthalmology
    Article 04 July 2024
  12. Reliability, stability during long-term storage, and intra-individual variation of circulating levels of osteopontin, osteoprotegerin, vascular endothelial growth factor-A, and interleukin-17A

    Background

    Studies in many populations have reported associations between circulating cytokine levels and various physiological or pathological...

    Tomoki Nakamizo, John Cologne, ... Waka Ohishi in European Journal of Medical Research
    Article Open access 17 February 2024
  13. Serum vascular endothelial growth factor affects tissue fluid accumulation and is associated with deteriorating tissue perfusion and oxygenation in severe sepsis: a prospective observational study

    Background

    Positive fluid balance and tissue fluid accumulation are associated with adverse outcomes in sepsis. Vascular endothelial growth factor...

    Chin-Kuo Lin, Ying-Huang Tsai, ... Bor-Shyh Lin in European Journal of Medical Research
    Article Open access 21 April 2023
  14. Characteristics of macular edema associated with retinal vein occlusion showing poor anatomic response to three loading anti-vascular endothelial growth factor injections: an optical coherence tomography analysis

    Purpose

    To analyze the clinical features of refractory cystoid macular edema related to retinal vein occlusion associated with the response to three...

    Mohammadkarim Johari, Alireza Attar, ... Seyed Ahmad Razavizadegan in BMC Ophthalmology
    Article Open access 22 January 2024
  15. Regular assessment of serum vascular endothelial growth factor levels to monitor POEMS syndrome

    Background

    To investigate the utility of regular serum VEGF (sVEGF) levels assessment in the monitoring of POEMS syndrome.

    Methods

    We retrospectively...

    Francesco Gentile, Fabrizia Terenghi, ... Eduardo Nobile-Orazio in Neurological Sciences
    Article Open access 13 September 2023
  16. Transcription factor FOXP1 mediates vascular endothelial dysfunction in diabetic retinopathy

    Background

    Diabetic retinopathy (DR) is still the fastest growing cause of blindness in working aged adults, and its typical characteristics are...

    Yekai Zhou, Yaling Xuan, ... Meixia An in Graefe's Archive for Clinical and Experimental Ophthalmology
    Article 13 June 2022
  17. Treatment results of diabetic macular edema with different choroidal thickness with intravitreal anti vascular endothelial growth factor

    Purpose

    To compare the results of intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy in patients with diabetic macular edema...

    Fatma Savur, Havva Kaldırım, ... Şerife Çiloğlu Hayat in BMC Ophthalmology
    Article Open access 22 December 2022
  18. Analyze of factors and prognosis of eyes lost to follow-up in retinal vein occlusive disease patients receiving anti-vascular endothelial growth factor therapy

    Background

    Patients with macular edema (ME) secondary to retinal vein occlusion (RVO) who received at least one intravitreal injection of...

    **aoying Huang, Minming Zheng, ... Zheng Zheng in BMC Ophthalmology
    Article Open access 12 June 2023
  19. Neuro-oncological Ventral Antigen 2 Regulates Splicing of Vascular Endothelial Growth Factor Receptor 1 and Is Required for Endothelial Function

    Pre-eclampsia (PE) affects 2–8% of pregnancies and is responsible for significant morbidity and mortality. The maternal clinical syndrome (defined by...

    Veerle Kremer, Jetta J. Oppelaar, ... Reinier A. Boon in Reproductive Sciences
    Article Open access 04 August 2022
Did you find what you were looking for? Share feedback.